Search Results - Jacob M Rowe

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Forward into the second century of Haematologica by Jacob M. Rowe

    Published in Haematologica (2020-11-01)
    Get full text
    Article


  2. 2

    Interpreting Outcome Data in Hematological Malignancies: A Paradigm for Clinical Studies by Jacob M. Rowe

    Published in Rambam Maimonides Medical Journal (2013-01-01)
    Get full text
    Article


  3. 3

    The “7+3” regimen in acute myeloid leukemia by Jacob M. Rowe

    Published in Haematologica (2022-01-01)
    Get full text
    Article


  4. 4

    Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia – the CONS by Yishai Ofran, Jacob M. Rowe

    Published in Haematologica (2025-01-01)
    Get full text
    Article


  5. 5

    Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia? by Ofrat Beyar-Katz, Jacob M. Rowe

    Published in Haematologica (2024-06-01)
    Get full text
    Article


  6. 6

    Traumatic vs. atraumatic 22 G needle for therapeutic and diagnostic lumbar puncture in the hematologic patient: a prospective clinical trial by Ronit Lavi, Jacob M. Rowe, Irit Avivi

    Published in Haematologica (2007-07-01)
    Get full text
    Article


  7. 7

    Toward further excellence in <i>Haematologica</i> by Jacob M. Rowe, Carlo Balduini, Jerry Radich

    Published in Haematologica (2022-01-01)
    Get full text
    Article


  8. 8

    Inhibition of FLT3: A Prototype for Molecular Targeted Therapy in Acute Myeloid Leukemia by Meira Yisraeli Salman, Jacob M. Rowe, Nir Weigert

    Published in Engineering (2021-10-01)
    Get full text
    Article


  9. 9

    Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia by Chezi Ganzel, Mira Kharit, Chen Duksin, Jacob M. Rowe

    Published in Haematologica (2018-10-01)
    Get full text
    Article


  10. 10

    Patterns of information-seeking for cancer on the internet: an analysis of real world data. by Yishai Ofran, Ora Paltiel, Dan Pelleg, Jacob M Rowe, Elad Yom-Tov

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  11. 11

    Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission by Marc Buyse, Stefan Michiels, Pierre Squifflet, Kathryn J. Lucchesi, Kristoffer Hellstrand, Mats L. Brune, Sylvie Castaigne, Jacob M. Rowe

    Published in Haematologica (2011-08-01)
    Get full text
    Article


  12. 12

    A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hod... by Eldad J. Dann, Rachel Bar-Shalom, Ada Tamir, Ron Epelbaum, Irit Avivi, Menachem Ben-Shachar, Diana Gaitini, Jacob M. Rowe

    Published in Haematologica (2010-07-01)
    Get full text
    Article


  13. 13

    Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction by Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein

    Published in Blood Advances (2025-07-01)
    Get full text
    Article


  14. 14

    BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study by Tsila Zuckerman, Ron Ram, Luiza Akria, Maya Koren-Michowitz, Ron Hoffman, Israel Henig, Noa Lavi, Yishai Ofran, Netanel A. Horowitz, Olga Nudelman, Sigal Tavor, Shay Yeganeh, Stela Gengrinovitch, Liat Flaishon, Shoshi Tessler, Ruth Ben Yakar, Jacob M. Rowe

    Published in Blood Advances (2019-11-01)
    Get full text
    Article


  15. 15

    Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900 by Hugo F. Fernandez, Zhuoxin Sun, Mark R. Litzow, Selina M. Luger, Elisabeth Paietta, Janis Racevskis, Ross L. Levine, Jay P. Patel, Omar Abdel-Wahab, Rhett P. Ketterling, Gordon W. Dewald, John M. Bennett, Jacob M. Rowe, Hillard M. Lazarus, Martin S. Tallman

    Published in Haematologica (2019-04-01)
    Get full text
    Article


  16. 16

    International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia by Nicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, Adele K. Fielding, Anjali Advani, Renato Bassan, Victoria Chia, Michael Doubek, Sebastian Giebel, Dieter Hoelzer, Norbert Ifrah, Aaron Katz, Michael Kelsh, Giovanni Martinelli, Mireia Morgades, Susan O’Brien, Jacob M. Rowe, Julia Stieglmaier, Martha Wadleigh, Hagop Kantarjian

    Published in Haematologica (2016-12-01)
    Get full text
    Article


  17. 17

    The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial by David I. Marks, Anthony V. Moorman, Lucy Chilton, Elisabeth Paietta, Amir Enshaie, Gordon DeWald, Christine J. Harrison, Adele K. Fielding, Letizia Foroni, Anthony H. Goldstone, Mark R. Litzow, Selina M. Luger, Andrew K. McMillan, Janis Racevskis, Jacob M. Rowe, Martin S. Tallman, Peter Wiernik, Hillard M. Lazarus

    Published in Haematologica (2013-06-01)
    Get full text
    Article


Search Tools: